Lucid Diagnostics (LUCD) Notes Payables (2023 - 2026)

Lucid Diagnostics' Notes Payables history runs 4 years deep, the most recent figure standing at $25.2 million for Q1 2026.

• Quarterly Notes Payables fell 23.17% year-over-year to $25.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.2 million (down 23.17% YoY) and the FY2025 annual result came in at $24.0 million, up 29.03% from the prior year.
• Notes Payables was $25.2 million for Q1 2026 at Lucid Diagnostics, up from $24.0 million in the prior quarter.
• Across five years, Notes Payables topped out at $32.8 million in Q1 2025 and bottomed at $10.2 million in Q3 2024.
• A 4-year average of $18.0 million and a median of $14.5 million in 2023 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2024 — Notes Payables slipped 29.61% — and 2025, when it jumped 150.38%.
• Lucid Diagnostics' Notes Payables stood at $14.0 million in 2023, then soared by 33.33% to $18.6 million in 2024, then increased by 29.03% to $24.0 million in 2025, then climbed by 5.0% to $25.2 million in 2026.
• Business Quant data shows LUCD's Notes Payables at $25.2 million in Q1 2026, $24.0 million in Q4 2025, and $22.3 million in Q3 2025.